Efficacy of anti-TNF-a agents seems inferior to IL-17 and IL-23 inhibitors. Nevertheless, after biosimilars approval, anti TNF-a agents are recommended as first-line for psoriatic patients, for economic reasons.

Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy / Zangrilli, Arianna; Caldarola, Giacomo; Bernardini, Nicoletta; Bavetta, Mauro; Graceffa, Dario; Bonifati, Claudio; Cantoresi, Franca; Faleri, Sara; Giordano, Domenico; Mariani, Marco; Micheli, Adriana; Moretta, Gaia; Pirro, Federico; Pagnanelli, Gianluca; Panasiti, Vincenzo; Provini, Alessia; Richetta, Antonio; Sacchelli, Lidia; Bianchi, Luca; Peris, Ketty. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1744-7682. - 21:9(2021), p. 1291-1298. [10.1080/14712598.2021.1948530]

Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy

Bernardini, Nicoletta;Cantoresi, Franca;Giordano, Domenico;Panasiti, Vincenzo;Richetta, Antonio;
2021

Abstract

Efficacy of anti-TNF-a agents seems inferior to IL-17 and IL-23 inhibitors. Nevertheless, after biosimilars approval, anti TNF-a agents are recommended as first-line for psoriatic patients, for economic reasons.
2021
Moderate-to-severe psoriasis; anti TNF a; biotechnological therapies; high need patients; predictive factors
01 Pubblicazione su rivista::01l Trial clinico
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy / Zangrilli, Arianna; Caldarola, Giacomo; Bernardini, Nicoletta; Bavetta, Mauro; Graceffa, Dario; Bonifati, Claudio; Cantoresi, Franca; Faleri, Sara; Giordano, Domenico; Mariani, Marco; Micheli, Adriana; Moretta, Gaia; Pirro, Federico; Pagnanelli, Gianluca; Panasiti, Vincenzo; Provini, Alessia; Richetta, Antonio; Sacchelli, Lidia; Bianchi, Luca; Peris, Ketty. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1744-7682. - 21:9(2021), p. 1291-1298. [10.1080/14712598.2021.1948530]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1574859
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact